Re:Cost of developing new drugs may be far lower than indust...
by kazinator on Friday April 26, 2024 @07:49PM
(#40175598)
If the government hands out grants, about which information is subsequently hard to get, that points to a gaping transparency issue squarely on the government side.
Pharma R&D companies that are publicly listed should have some information about their balance sheets.
Private equity ones are going to be the most opaque. That's kind of their prerogative.
Pharma R&D companies that are publicly listed should have some information about their balance sheets.
Private equity ones are going to be the most opaque. That's kind of their prerogative.